©The Author(s) 2026.
World J Diabetes. Feb 15, 2026; 17(2): 112859
Published online Feb 15, 2026. doi: 10.4239/wjd.v17.i2.112859
Published online Feb 15, 2026. doi: 10.4239/wjd.v17.i2.112859
Table 3 Univariate logistic regression analysis of clinical indicators and bile acids in the type 2 diabetes mellitus and diabetic gastric autonomic neuropathy groups
| Variables | Univariate logistic regression analysis | |
| OR (95%CI) | P value | |
| Clinical indicators | ||
| Gender, F, % | 1.131 (0.436-2.935) | 0.800 |
| Age, years | 0.941 (0.904-0.978) | 0.002b |
| BMI, kg/m2 | 0.759 (0.635-0.907) | 0.002b |
| Duration of diabetes, months | 1.002 (0.997-1.008) | 0.388 |
| SBP, mmHg | 0.999 (0.973-1.025) | 0.929 |
| DBP, mmHg | 1.029 (0.988-1.071) | 0.172 |
| WBC, × 109/L | 0.855 (0.650-1.123) | 0.260 |
| Hb, g/L | 0.962 (0.936-0.989) | 0.006b |
| PLT, × 109/L | 1.000 (0.992-1.008) | 0.995 |
| CRP, mg/L | 1.068 (0.987-1.157) | 0.103 |
| FBG, mmol/L | 0.874 (0.732-1.044) | 0.137 |
| HbA1c, % | 0.895 (0.720-1.113) | 0.320 |
| FC-P, nmol/L | 0.062 (0.011-0.339) | 0.001b |
| 2hC-P, nmol/L | 0.185 (0.078-0.438) | < 0.001b |
| BUN, mmol/L | 0.873 (0.683-1.117) | 0.281 |
| SCr, µmol/L | 1.004 (0.991-1.017) | 0.555 |
| eGFR, mL/min/1.73 m2 | 1.013 (0.990-1.036) | 0.264 |
| UACR, mg/g | 1.001 (1.000-1.003) | 0.037a |
| TG, mmol/L | 0.551 (0.327-1.929) | 0.065 |
| TC, mmol/L | 0.985 (0.677-1.433) | 0.937 |
| LDL-C, mmol/L | 0.864 (0.540-1.382) | 0.542 |
| HDL-C, mmol/L | 0.393 (0.052-2.972) | 0.365 |
| ALB, g/L | 0.895 (0.808-0.992) | 0.034a |
| ALT, U/L | 0.960 (0.916-1.006) | 0.088 |
| AST, U/L | 0.948 (0.887-1.012) | 0.111 |
| BAs characteristics | ||
| CA, nmol/L | 1.001 (1.000-1.002) | 0.070 |
| DCA, nmol/L | 1.000 (0.999-1.001) | 0.813 |
| CDCA, nmol/L | 1.000 (1.000-1.001) | 0.386 |
| UDCA, nmol/L | 0.997 (0.993-1.001) | 0.169 |
| LCA, nmol/L | 0.996 (0.979-1.014) | 0.673 |
| GCA, nmol/L | 1.000 (1.000-1.001) | 0.276 |
| GLCA, nmol/L | 0.948 (0.886-1.014) | 0.120 |
| GDCA, nmol/L | 1.000 (0.999-1.001) | 0.663 |
| GCDCA, nmol/L | 1.000 (1.000-1.000) | 0.832 |
| GUDCA, nmol/L | 0.999 (0.996-1.002) | 0.561 |
| TCA, nmol/L | 1.003 (0.998-1.007) | 0.226 |
| TLCA, nmol/L | 0.603 (0.377-0.964) | 0.035a |
| TDCA, nmol/L | 0.985 (0.968-1.003) | 0.106 |
| TCDCA, nmol/L | 1.001 (0.999-1.003) | 0.201 |
| TUDCA, nmol/L | 1.014 (0.986-1.043) | 0.333 |
- Citation: Zhu KY, Wang SJ, Li J, Ma PP, Feng SS, Guo L, Lu YB, Dong L, Ding DF. Association of serum bile acid profiles with the risk of gastrointestinal autonomic neuropathy in patients with type 2 diabetes mellitus. World J Diabetes 2026; 17(2): 112859
- URL: https://www.wjgnet.com/1948-9358/full/v17/i2/112859.htm
- DOI: https://dx.doi.org/10.4239/wjd.v17.i2.112859